Related Experiment Video
Updated: Sep 6, 2025

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Statin use before and after the KDIGO Lipids in chronic kidney disease guideline: A population-based interrupted time
Jan D Kampmann1,2, Mads Nybo3, Frans Brandt1,2
1Internal Medicine Research Unit, University Hospital of Southern Denmark, Odense, Denmark.
Abstract:
In November 2013, the Kidney Disease: Improving Global Outcomes Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease was published, recommending statins for all individuals 50 years or older with an estimated glomerular filtration rate below 60 ml/min/1.73 m2 to lower the risk of major cardiovascular events. We quantified the prevalence of statin use among the target population before and after the guideline publication in a large Danish cohort of individuals with an estimated glomerular filtration rate below 60 ml/min/1.73 m2 , to investigate the effect of the guideline, but found no difference in the prevalence of statin use prior to and after the guideline publication.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction
Atherosclerosis III: Management
Chronic Kidney Disease IV: Nursing Management

